7th Annual Pharma IPR Conference 2018

CPhI’s 7th Annual Pharma IPR Conference happening on 7-9 March 2018, Mumbai is a leading platform for Indian pharmaceutical companies to interact with the IP Attorneys and Counsels from across the globe and discuss the recent trends and best practices in the pharma IPR space. Since 2012, Pharma IPR Conference has focused on importance of Intellectual Property in Pharma syncing it with business objectives of Indian Pharma companies.

This three-day conference will provide ample opportunities for business networking with visionary entrepreneurs and industry experts around the world.

Each one of our speakers is an expert in their respective field with years of experience. Join us at this conference for your chance to hear these IP specialists from various countries, as they share with you the latest trends, insights and strategies for patent procurement, litigation and other topical IP issues.

USA

  • Analyzing the impact of New GDUFA II User Fee Structure
  • Five years of Inter Partes Review : Effectiveness and Expectations
  • Solving a roadblock: Increasing efficiency while limiting the US Litigation Costs
  • Updates on ANDA filing and litigation
  • Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access
  • Risk Evaluation and Mitigation Strategies (REMS): Update
  • Patent framework for amplified Biosimilars space : Detailed understanding

Europe

  • Understanding the Unitary Patent System
  • Patent Term Extension and Supplementary Protection Certificate regime (SPCs)
  • Implications of IP enforcement on trademarks on Indian exports
  • Biosimilars litigation in Europe
  • Implications of Brexit on Indian pharma companies

Top Reason to attend


Reinforce your position as an IP thought leader in the Indian Pharma Industry
Interact with Indian and International patent experts
Get highly effective solutions to the global pharma IPR related queries
Harness the learnings from recent cases to understand pharma patent litigation laws
Take advantage of focused networking sessions to enter into strategic partnerships
Strategise effective market entry into 10+ countries including US and Europe.